Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2941 to 2955 of 7690 results

  1. Quality standards: process guide (PMG43)

    This guide describes the process NICE uses to develop NICE quality standards

  2. Our role in the Innovative Licensing and Access Pathway (ILAP)

    The Innovative Licensing and Access Pathway (ILAP) aims to streamline patient access to safe, financially sustainable and innovative medicines.

  3. Overview: how we develop technology appraisal guidance

    1. Provisional appraisal topics chosen The NICE topic selection programme produces a list of provisional appraisal topics. 2. Stakeholders identified

  4. Developing NICE guidelines: the manual (PMG20)

    This manual explains the processes and methods used to develop and update NICE guidelines, the guidance that NICE develops covering topics across clinical care (in primary, secondary and community care settings), social care and public health. For more information on the other types of NICE guidance and advice (including technology appraisal guidance), see about NICE

  5. Biosimilar technologies: NICE position statement

    There are 2 different points of the lifecycle of a NICE Technology Appraisal at which consideration of reference to or inclusion of a biosimilar is...

  6. Biosimilar technologies: NICE position statement - information for the public

    Biosimilar medicines – NICE's approach A biological medicine is any medicinal product made by or derived from a biological (natural) source, for...

  7. Participation in clinical trials and subsequent access to drugs appraised by NICE: a statement on the applicability of technology appraisal guidance

    Patients taking part in clinical trials may receive drugs which have been evaluated by NICE technology appraisal guidance. Queries have been raised...

  8. Technology appraisal position statements

    On this page, you'll find a list of all our position statements relating to our technology appraisal guidance. Biosimilar technologies: NICE position

  9. Technology appraisals - position statements

    On this page, you'll find all our position statements relating to technology appraisals. Biosimilar technologies: NICE position statement Biosimilar

  10. Methods research areas

    NICE priority methodological research areas.

  11. Partnering with us for research - timescales and process

    Whether you are a researcher, funder, charity or policy organisation, you can partner with us for methodological research. As one of the leading...

  12. Supporting the health and care system to implement virtual wards

    Virtual wards (also known as hospital at home) provide hospital level care at home. People on a virtual ward are cared for by a multidisciplinary team

  13. Taking a proportionate approach to technology appraisals

    Find out more about NICE's new proportionate approach to technology appraisals

  14. 5-year equality, diversity and inclusion (EDI) roadmap and annual action plan

    We're committed to creating a forward-looking, positive work culture where everyone can thrive. Our 5-year equality, diversity and inclusion (EDI)...

  15. Charging procedure: technology appraisal and highly specialised technologies evaluations

    Introduction In accordance with UK Statutory Instrument 2018 No.1322 , NICE must recover its costs for producing Technology Appraisals (TA) or Highly